Hydrogel-Based Delivery Systems for Pro-Healing Bacteria in Wound Treatment Microenvironment

This hydrogel-based delivery system represents a paradigm shift in wound care by leveraging the therapeutic potential of pro-healing bacteria.

Technology

Chronic wounds, such as diabetic foot ulcers, present significant challenges in healthcare due to their persistent nature and the high costs associated with their treatment. Traditional approaches focus on eradicating pathogenic bacteria and promoting mammalian cell activities, yet these methods often fail to achieve complete wound closure. The need for innovative delivery systems that harness beneficial bacteria to modulate the wound microenvironment is critical. UD Researchers have developed a hydrogel-based biomaterial system designed to encapsulate and deliver pro-healing bacteria directly to wound sites. The platform addresses the problem of ineffective wound closure in chronic wounds by providing a delivery system that ensures precise control over the release and activity of therapeutic bacteria. Additionally, it overcomes the challenge of insufficient modulation of the wound microenvironment by allowing for the tuning of hydrogel properties, including mesh size and degradability, to promote healing. The transition from bulk hydrogels to microgels further enhances dosage control and delivery precision. This hydrogel-based delivery system represents a paradigm shift in wound care by leveraging the therapeutic potential of pro-healing bacteria. By ensuring precise delivery and sustained activity of beneficial microbes, this technology promises to significantly enhance healing outcomes, reduce treatment costs, and improve the quality of life for patients with chronic wounds.

Benefits

  • Supports the viability and controlled release of pro-healing bacteria
  • Provides precise control over dosage and delivery through microgel systems
  • Offers a novel approach to modulate the wound microenvironment, potentially improving healing rates and outcomes

Applications

  • Treatment of chronic wounds
  • Medical applications requiring the delivery and biocontainment of therapeutic bacteria
  • Enhancement of skin microbiome modulation for improved wound healing outcomes